HEADER DE NOVO PROTEIN 29-MAY-13 4KYZ TITLE THREE-DIMENSIONAL STRUCTURE OF TRICLINIC FORM OF DE NOVO DESIGN TITLE 2 INSERTION DOMAIN, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TITLE 3 TARGET OR327 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DESIGNED PROTEIN OR327; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+ MAGIC; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET21_NESG KEYWDS STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, KEYWDS 2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, DOMAIN INSERTION, DE KEYWDS 3 NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.KUZIN,M.SU,J.SEETHARAMAN,M.MAGLAQUI,R.XIAO,D.LEE,J.GLEIXNER, AUTHOR 2 D.BAKER,J.K.EVERETT,T.B.ACTON,G.KORNHABER,G.T.MONTELIONE,J.F.HUNT, AUTHOR 3 L.TONG,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 6 06-DEC-23 4KYZ 1 REMARK REVDAT 5 20-SEP-23 4KYZ 1 LINK REVDAT 4 17-FEB-16 4KYZ 1 JRNL REVDAT 3 13-JAN-16 4KYZ 1 JRNL REVDAT 2 23-DEC-15 4KYZ 1 JRNL REVDAT 1 24-JUL-13 4KYZ 0 JRNL AUTH I.C.KING,J.GLEIXNER,L.DOYLE,A.KUZIN,J.F.HUNT,R.XIAO, JRNL AUTH 2 G.T.MONTELIONE,B.L.STODDARD,F.DIMAIO,D.BAKER JRNL TITL PRECISE ASSEMBLY OF COMPLEX BETA SHEET TOPOLOGIES FROM DE JRNL TITL 2 NOVO DESIGNED BUILDING BLOCKS. JRNL REF ELIFE V. 4 2015 JRNL REFN ESSN 2050-084X JRNL PMID 26650357 JRNL DOI 10.7554/ELIFE.11012 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1269 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.520 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 23724 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1187 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4590 - 4.9770 0.98 2936 155 0.1750 0.2240 REMARK 3 2 4.9770 - 3.9540 0.99 2930 154 0.1640 0.2240 REMARK 3 3 3.9540 - 3.4550 0.97 2880 152 0.1910 0.2620 REMARK 3 4 3.4550 - 3.1390 0.94 2802 147 0.2090 0.2890 REMARK 3 5 3.1390 - 2.9140 0.95 2806 148 0.2210 0.2920 REMARK 3 6 2.9140 - 2.7430 0.95 2848 150 0.2040 0.2770 REMARK 3 7 2.7430 - 2.6050 0.95 2808 148 0.2230 0.2850 REMARK 3 8 2.6050 - 2.4920 0.84 2527 133 0.2350 0.3280 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5412 REMARK 3 ANGLE : 1.077 7284 REMARK 3 CHIRALITY : 0.071 856 REMARK 3 PLANARITY : 0.004 932 REMARK 3 DIHEDRAL : 15.104 2060 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4KYZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-13. REMARK 100 THE DEPOSITION ID IS D_1000079971. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23740 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.492 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 4KY3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 100MM NACL, 5MM DTT, REMARK 280 0.02% NAN3, 10MM TRIS-HCL (PH 7.5) . RESERVOIR SOLUTION:0.1M REMARK 280 NH4H2PO4 0.1M TRIS PEG8K 20% , MICROBATCH UNDER OIL, TEMPERATURE REMARK 280 277K, PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER,19.75 KD,99.6% REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 GLY A 2 REMARK 465 HIS A 170 REMARK 465 HIS A 171 REMARK 465 HIS A 172 REMARK 465 MSE B 1 REMARK 465 GLY B 2 REMARK 465 HIS B 170 REMARK 465 HIS B 171 REMARK 465 HIS B 172 REMARK 465 MSE C 1 REMARK 465 GLY C 2 REMARK 465 HIS C 170 REMARK 465 HIS C 171 REMARK 465 HIS C 172 REMARK 465 MSE D 1 REMARK 465 GLY D 2 REMARK 465 HIS D 170 REMARK 465 HIS D 171 REMARK 465 HIS D 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG D 88 O HOH D 240 1.93 REMARK 500 NH1 ARG D 81 O HOH D 229 1.98 REMARK 500 O HOH B 213 O HOH B 238 2.01 REMARK 500 N ASP D 3 O HOH D 211 2.06 REMARK 500 NZ LYS C 146 O HOH C 221 2.10 REMARK 500 O HOH A 238 O HOH B 228 2.12 REMARK 500 O GLU A 93 O HOH A 232 2.16 REMARK 500 O HOH B 210 O HOH B 221 2.18 REMARK 500 NZ LYS D 15 O HOH D 239 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 46.07 -108.01 REMARK 500 ASN A 13 115.94 26.33 REMARK 500 ASP A 78 84.73 -62.39 REMARK 500 ASN A 80 127.10 -173.75 REMARK 500 PHE A 109 33.34 -98.30 REMARK 500 ALA A 110 12.44 59.65 REMARK 500 ASP B 12 59.45 -105.00 REMARK 500 ASN B 13 143.27 -29.02 REMARK 500 ASP B 78 86.28 -49.22 REMARK 500 ASP B 91 94.89 -63.52 REMARK 500 ASN C 13 104.02 58.21 REMARK 500 ASP C 78 96.30 -61.26 REMARK 500 ASN D 13 96.74 55.20 REMARK 500 ASN D 16 129.52 -175.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4KY3 RELATED DB: PDB REMARK 900 100% IDENTITY REMARK 900 RELATED ID: NESG-OR327 RELATED DB: TARGETTRACK DBREF 4KYZ A 1 172 PDB 4KYZ 4KYZ 1 172 DBREF 4KYZ B 1 172 PDB 4KYZ 4KYZ 1 172 DBREF 4KYZ C 1 172 PDB 4KYZ 4KYZ 1 172 DBREF 4KYZ D 1 172 PDB 4KYZ 4KYZ 1 172 SEQRES 1 A 172 MSE GLY ASP ILE GLN VAL GLN VAL ASN ILE ASP ASP ASN SEQRES 2 A 172 GLY LYS ASN PHE ASP TYR THR TYR THR VAL THR THR GLU SEQRES 3 A 172 SER GLU LEU GLN LYS VAL LEU ASN GLU LEU MSE ASP TYR SEQRES 4 A 172 ILE LYS LYS GLN GLY ALA LYS ARG VAL ARG ILE SER ILE SEQRES 5 A 172 THR ALA ARG SER SER LYS GLU ALA TYR LYS PHE LEU ALA SEQRES 6 A 172 ILE LEU ALA LYS VAL PHE ALA GLU LEU GLY TYR ASN ASP SEQRES 7 A 172 ILE ASN ARG LYS MSE THR VAL ARG PHE ARG GLY ASP ASP SEQRES 8 A 172 LEU GLU ALA LEU GLU LYS ALA LEU LYS GLU MSE ILE ARG SEQRES 9 A 172 GLN ALA ARG LYS PHE ALA GLY THR VAL THR TYR THR LEU SEQRES 10 A 172 ASP GLY ASN ASP LEU GLU ILE THR ILE THR GLY VAL PRO SEQRES 11 A 172 ARG GLN VAL LEU GLU GLU LEU ALA LYS GLU ALA GLU ARG SEQRES 12 A 172 LEU ALA LYS GLU PHE ASN ILE THR ILE THR ILE THR VAL SEQRES 13 A 172 THR VAL GLU GLY GLN LEU GLY SER LEU GLU HIS HIS HIS SEQRES 14 A 172 HIS HIS HIS SEQRES 1 B 172 MSE GLY ASP ILE GLN VAL GLN VAL ASN ILE ASP ASP ASN SEQRES 2 B 172 GLY LYS ASN PHE ASP TYR THR TYR THR VAL THR THR GLU SEQRES 3 B 172 SER GLU LEU GLN LYS VAL LEU ASN GLU LEU MSE ASP TYR SEQRES 4 B 172 ILE LYS LYS GLN GLY ALA LYS ARG VAL ARG ILE SER ILE SEQRES 5 B 172 THR ALA ARG SER SER LYS GLU ALA TYR LYS PHE LEU ALA SEQRES 6 B 172 ILE LEU ALA LYS VAL PHE ALA GLU LEU GLY TYR ASN ASP SEQRES 7 B 172 ILE ASN ARG LYS MSE THR VAL ARG PHE ARG GLY ASP ASP SEQRES 8 B 172 LEU GLU ALA LEU GLU LYS ALA LEU LYS GLU MSE ILE ARG SEQRES 9 B 172 GLN ALA ARG LYS PHE ALA GLY THR VAL THR TYR THR LEU SEQRES 10 B 172 ASP GLY ASN ASP LEU GLU ILE THR ILE THR GLY VAL PRO SEQRES 11 B 172 ARG GLN VAL LEU GLU GLU LEU ALA LYS GLU ALA GLU ARG SEQRES 12 B 172 LEU ALA LYS GLU PHE ASN ILE THR ILE THR ILE THR VAL SEQRES 13 B 172 THR VAL GLU GLY GLN LEU GLY SER LEU GLU HIS HIS HIS SEQRES 14 B 172 HIS HIS HIS SEQRES 1 C 172 MSE GLY ASP ILE GLN VAL GLN VAL ASN ILE ASP ASP ASN SEQRES 2 C 172 GLY LYS ASN PHE ASP TYR THR TYR THR VAL THR THR GLU SEQRES 3 C 172 SER GLU LEU GLN LYS VAL LEU ASN GLU LEU MSE ASP TYR SEQRES 4 C 172 ILE LYS LYS GLN GLY ALA LYS ARG VAL ARG ILE SER ILE SEQRES 5 C 172 THR ALA ARG SER SER LYS GLU ALA TYR LYS PHE LEU ALA SEQRES 6 C 172 ILE LEU ALA LYS VAL PHE ALA GLU LEU GLY TYR ASN ASP SEQRES 7 C 172 ILE ASN ARG LYS MSE THR VAL ARG PHE ARG GLY ASP ASP SEQRES 8 C 172 LEU GLU ALA LEU GLU LYS ALA LEU LYS GLU MSE ILE ARG SEQRES 9 C 172 GLN ALA ARG LYS PHE ALA GLY THR VAL THR TYR THR LEU SEQRES 10 C 172 ASP GLY ASN ASP LEU GLU ILE THR ILE THR GLY VAL PRO SEQRES 11 C 172 ARG GLN VAL LEU GLU GLU LEU ALA LYS GLU ALA GLU ARG SEQRES 12 C 172 LEU ALA LYS GLU PHE ASN ILE THR ILE THR ILE THR VAL SEQRES 13 C 172 THR VAL GLU GLY GLN LEU GLY SER LEU GLU HIS HIS HIS SEQRES 14 C 172 HIS HIS HIS SEQRES 1 D 172 MSE GLY ASP ILE GLN VAL GLN VAL ASN ILE ASP ASP ASN SEQRES 2 D 172 GLY LYS ASN PHE ASP TYR THR TYR THR VAL THR THR GLU SEQRES 3 D 172 SER GLU LEU GLN LYS VAL LEU ASN GLU LEU MSE ASP TYR SEQRES 4 D 172 ILE LYS LYS GLN GLY ALA LYS ARG VAL ARG ILE SER ILE SEQRES 5 D 172 THR ALA ARG SER SER LYS GLU ALA TYR LYS PHE LEU ALA SEQRES 6 D 172 ILE LEU ALA LYS VAL PHE ALA GLU LEU GLY TYR ASN ASP SEQRES 7 D 172 ILE ASN ARG LYS MSE THR VAL ARG PHE ARG GLY ASP ASP SEQRES 8 D 172 LEU GLU ALA LEU GLU LYS ALA LEU LYS GLU MSE ILE ARG SEQRES 9 D 172 GLN ALA ARG LYS PHE ALA GLY THR VAL THR TYR THR LEU SEQRES 10 D 172 ASP GLY ASN ASP LEU GLU ILE THR ILE THR GLY VAL PRO SEQRES 11 D 172 ARG GLN VAL LEU GLU GLU LEU ALA LYS GLU ALA GLU ARG SEQRES 12 D 172 LEU ALA LYS GLU PHE ASN ILE THR ILE THR ILE THR VAL SEQRES 13 D 172 THR VAL GLU GLY GLN LEU GLY SER LEU GLU HIS HIS HIS SEQRES 14 D 172 HIS HIS HIS MODRES 4KYZ MSE A 37 MET SELENOMETHIONINE MODRES 4KYZ MSE A 83 MET SELENOMETHIONINE MODRES 4KYZ MSE A 102 MET SELENOMETHIONINE MODRES 4KYZ MSE B 37 MET SELENOMETHIONINE MODRES 4KYZ MSE B 83 MET SELENOMETHIONINE MODRES 4KYZ MSE B 102 MET SELENOMETHIONINE MODRES 4KYZ MSE C 37 MET SELENOMETHIONINE MODRES 4KYZ MSE C 83 MET SELENOMETHIONINE MODRES 4KYZ MSE C 102 MET SELENOMETHIONINE MODRES 4KYZ MSE D 37 MET SELENOMETHIONINE MODRES 4KYZ MSE D 83 MET SELENOMETHIONINE MODRES 4KYZ MSE D 102 MET SELENOMETHIONINE HET MSE A 37 8 HET MSE A 83 8 HET MSE A 102 8 HET MSE B 37 8 HET MSE B 83 8 HET MSE B 102 8 HET MSE C 37 8 HET MSE C 83 8 HET MSE C 102 8 HET MSE D 37 8 HET MSE D 83 8 HET MSE D 102 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 5 HOH *169(H2 O) HELIX 1 1 THR A 25 GLY A 44 1 20 HELIX 2 2 SER A 56 GLY A 75 1 20 HELIX 3 3 ASP A 91 PHE A 109 1 19 HELIX 4 4 PRO A 130 PHE A 148 1 19 HELIX 5 5 SER A 164 HIS A 169 1 6 HELIX 6 6 THR B 25 GLY B 44 1 20 HELIX 7 7 SER B 56 GLY B 75 1 20 HELIX 8 8 ASP B 91 PHE B 109 1 19 HELIX 9 9 PRO B 130 PHE B 148 1 19 HELIX 10 10 SER B 164 HIS B 169 1 6 HELIX 11 11 THR C 25 GLY C 44 1 20 HELIX 12 12 SER C 56 GLY C 75 1 20 HELIX 13 13 ASP C 91 PHE C 109 1 19 HELIX 14 14 PRO C 130 ASN C 149 1 20 HELIX 15 15 SER C 164 HIS C 169 1 6 HELIX 16 16 THR D 25 GLY D 44 1 20 HELIX 17 17 SER D 56 GLY D 75 1 20 HELIX 18 18 ASP D 91 PHE D 109 1 19 HELIX 19 19 PRO D 130 ASN D 149 1 20 HELIX 20 20 SER D 164 HIS D 169 1 6 SHEET 1 A 7 ASN A 16 VAL A 23 0 SHEET 2 A 7 ILE A 4 ASP A 11 -1 N ILE A 4 O VAL A 23 SHEET 3 A 7 ARG A 47 ALA A 54 -1 O ARG A 49 N ASN A 9 SHEET 4 A 7 THR A 151 LEU A 162 -1 O ILE A 154 N ALA A 54 SHEET 5 A 7 TYR A 76 ARG A 88 -1 N THR A 84 O THR A 155 SHEET 6 A 7 ASP A 121 THR A 127 -1 O ILE A 124 N VAL A 85 SHEET 7 A 7 THR A 112 ASP A 118 -1 N THR A 114 O THR A 125 SHEET 1 B 7 LYS B 15 VAL B 23 0 SHEET 2 B 7 ILE B 4 ASP B 12 -1 N VAL B 6 O TYR B 21 SHEET 3 B 7 ARG B 47 ALA B 54 -1 O ARG B 47 N ASP B 11 SHEET 4 B 7 THR B 151 LEU B 162 -1 O ILE B 154 N ALA B 54 SHEET 5 B 7 TYR B 76 ARG B 88 -1 N ASN B 77 O GLN B 161 SHEET 6 B 7 ASP B 121 THR B 127 -1 O LEU B 122 N PHE B 87 SHEET 7 B 7 THR B 112 ASP B 118 -1 N THR B 114 O THR B 125 SHEET 1 C 7 ASN C 16 VAL C 23 0 SHEET 2 C 7 ILE C 4 ASP C 11 -1 N ILE C 10 O PHE C 17 SHEET 3 C 7 ARG C 47 ALA C 54 -1 O THR C 53 N GLN C 5 SHEET 4 C 7 THR C 151 LEU C 162 -1 O ILE C 154 N ALA C 54 SHEET 5 C 7 TYR C 76 ARG C 88 -1 N THR C 84 O THR C 155 SHEET 6 C 7 ASP C 121 THR C 127 -1 O ILE C 124 N VAL C 85 SHEET 7 C 7 THR C 112 ASP C 118 -1 N THR C 114 O THR C 125 SHEET 1 D 7 ASN D 16 VAL D 23 0 SHEET 2 D 7 ILE D 4 ASP D 11 -1 N ILE D 10 O PHE D 17 SHEET 3 D 7 ARG D 47 ALA D 54 -1 O THR D 53 N GLN D 5 SHEET 4 D 7 THR D 151 LEU D 162 -1 O VAL D 156 N ILE D 52 SHEET 5 D 7 TYR D 76 ARG D 88 -1 N THR D 84 O THR D 155 SHEET 6 D 7 ASP D 121 THR D 127 -1 O ILE D 124 N VAL D 85 SHEET 7 D 7 THR D 112 ASP D 118 -1 N THR D 114 O THR D 125 LINK C LEU A 36 N MSE A 37 1555 1555 1.33 LINK C MSE A 37 N ASP A 38 1555 1555 1.33 LINK C LYS A 82 N MSE A 83 1555 1555 1.32 LINK C MSE A 83 N THR A 84 1555 1555 1.32 LINK C GLU A 101 N MSE A 102 1555 1555 1.33 LINK C MSE A 102 N ILE A 103 1555 1555 1.32 LINK C LEU B 36 N MSE B 37 1555 1555 1.33 LINK C MSE B 37 N ASP B 38 1555 1555 1.33 LINK C LYS B 82 N MSE B 83 1555 1555 1.32 LINK C MSE B 83 N THR B 84 1555 1555 1.32 LINK C GLU B 101 N MSE B 102 1555 1555 1.33 LINK C MSE B 102 N ILE B 103 1555 1555 1.33 LINK C LEU C 36 N MSE C 37 1555 1555 1.32 LINK C MSE C 37 N ASP C 38 1555 1555 1.33 LINK C LYS C 82 N MSE C 83 1555 1555 1.33 LINK C MSE C 83 N THR C 84 1555 1555 1.33 LINK C GLU C 101 N MSE C 102 1555 1555 1.33 LINK C MSE C 102 N ILE C 103 1555 1555 1.33 LINK C LEU D 36 N MSE D 37 1555 1555 1.32 LINK C MSE D 37 N ASP D 38 1555 1555 1.33 LINK C LYS D 82 N MSE D 83 1555 1555 1.32 LINK C MSE D 83 N THR D 84 1555 1555 1.32 LINK C GLU D 101 N MSE D 102 1555 1555 1.33 LINK C MSE D 102 N ILE D 103 1555 1555 1.32 CRYST1 43.819 55.402 78.258 82.03 80.34 90.03 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022821 0.000013 -0.003926 0.00000 SCALE2 0.000000 0.018050 -0.002567 0.00000 SCALE3 0.000000 0.000000 0.013093 0.00000